ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $668,000 | -3.9% | 34,524 | -1.3% | 0.66% | +5.7% |
| Q2 2022 | $695,000 | -34.4% | 34,991 | -1.4% | 0.63% | -13.1% |
| Q1 2022 | $1,059,000 | +17.8% | 35,488 | -8.1% | 0.72% | +22.7% |
| Q4 2021 | $899,000 | -16.0% | 38,601 | +12.5% | 0.59% | -13.4% |
| Q3 2021 | $1,070,000 | +21.3% | 34,301 | +36.7% | 0.68% | +21.0% |
| Q2 2021 | $882,000 | +90.9% | 25,097 | +91.7% | 0.56% | +79.9% |
| Q1 2021 | $462,000 | +15.5% | 13,094 | +22.8% | 0.31% | +17.7% |
| Q4 2020 | $400,000 | – | 10,661 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 270,146 | $6,627,000 | 3.42% |
| Perceptive Advisors | 1,704,330 | $39,506,000 | 1.50% |
| Birchview Capital, LP | 38,000 | $932,000 | 0.88% |
| SECTORAL ASSET MANAGEMENT INC | 229,978 | $5,641,000 | 0.77% |
| BVF INC/IL | 200,500 | $4,918,000 | 0.64% |
| Artal Group S.A. | 500,000 | $12,265,000 | 0.45% |
| PA Capital LLC | 14,692 | $360,000 | 0.38% |
| Chicago Capital, LLC | 180,911 | $4,438,000 | 0.36% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $17,573,000 | 0.28% |
| Fosun International Ltd | 197,005 | $4,492,000 | 0.27% |